emoxypine succinate has been researched along with Apoplexy in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 15 (71.43) | 24.3611 |
| 2020's | 5 (23.81) | 2.80 |
| Authors | Studies |
|---|---|
| Kantemirova, FS; Karpov, SM; Morozova, MY; Muravyov, KA; Vyshlova, IA | 1 |
| Bagmanyan, SJ; Chukanova, AS; Chukanova, EI; Gulieva, MS; Kotel'nikova, SO; Kraineva, VA; Val'dman, EA; Voronina, TA; Zolotov, NN | 1 |
| Androfagina, OV; Strelnikova, IA; Svetkina, AA | 1 |
| Mkhitaryan, EA; Ostroumova, OD; Ostroumova, TM; Stakhovskaya, LV; Tkacheva, ON | 1 |
| Domashenko, MA; Konstantinov, VI; Loskutnikov, MA; Proskuryakova, OS; Shchukina, EP; Trushina, IA; Vakin, TM | 1 |
| Gudasheva, TA; Povarnina, PY; Seredenin, SB; Volkova, AA | 1 |
| Aliev, OI; Plotnikov, DM; Stegmeier, MN | 1 |
| Kispaeva, TT | 1 |
| Novikova, LB; Sarafutdinova, LR; Sharapova, KM | 1 |
| Barulin, AE; Konovalova, OV; Kurushina, OV | 1 |
| Golokhvastov, SIu; Ianishevskiĭ, SN; Odinak, MM; Trufanov, AG; Tsygan, NV; Vozniuk, IA | 1 |
| Koval'chuk, VV | 3 |
| Chipova, DT; Dolgova, NA; Nikolaev, YA; Shchepankevich, LA | 1 |
| Chugunov, AV; Kamchatnov, PR; Mikhaĭlova, NA | 1 |
| Lutskiĭ, MA | 1 |
| Izhbul'dina, GI | 1 |
| Chefranova, ZhIu; Koledintseva, EV; Makotrova, TA; Udachin, VA | 1 |
| Iurchenko, FV; Kuznetsov, VV | 1 |
| Ivanova, KV; Samartsev, IN; Zhivolupov, SA | 1 |
2 review(s) available for emoxypine succinate and Apoplexy
| Article | Year |
|---|---|
[Preventive/therapeutic correction of the development and progression of cognitive deficit in patients after stroke].
Topics: Cognition; Cognition Disorders; Disease Progression; Humans; Picolines; Psychotropic Drugs; Stroke; Treatment Outcome | 2013 |
[Correction of free-radical oxidation as a pathogenetic approach to the treatment of acute ischemic stroke].
Topics: Antioxidants; Brain Ischemia; Free Radical Scavengers; Humans; Oxidation-Reduction; Picolines; Stroke; Treatment Outcome | 2009 |
7 trial(s) available for emoxypine succinate and Apoplexy
| Article | Year |
|---|---|
[Study of the efficacy and safety of sequential use of the drugs Mexidol and Mexidol FORTE 250 in the treatment of stroke].
Topics: Brain Ischemia; Female; Humans; Male; Pharmaceutical Preparations; Picolines; Stroke | 2022 |
[The efficacy and safety of Mexidol Forte 250 as part of long-term sequential therapy in patients with carotid stroke].
Topics: Brain Ischemia; Carotid Artery Diseases; Humans; Picolines; Stroke; Treatment Outcome | 2020 |
[Efficacy and safety of mexidol across age groups in the acute and early recovery stages of hemispheric ischemic stroke (results of additional sub-analysis of a randomized double blind multicenter placebo-controlled study, in parallel groups trial EPICA)]
Topics: Aged; Aged, 80 and over; Brain Ischemia; Female; Humans; Male; Middle Aged; Picolines; Quality of Life; Stroke | 2020 |
[The use of mexidol in acute period of ischemic stroke].
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Female; Hemostasis; Humans; Male; Middle Aged; Picolines; Stroke | 2013 |
[The use of succinates for the correction of metabolic disorders in the penumbra in patients with stroke].
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Brain; Glucose; Humans; Inositol; Lactates; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Metabolic Diseases; Middle Aged; Oxidation-Reduction; Picolines; Severity of Illness Index; Stroke; Succinates | 2013 |
[An analysis of mexidol efficacy in the complex treatment of patients with ischemic stroke].
Topics: Aged; Antioxidants; Female; Humans; Male; Middle Aged; Picolines; Stroke; Treatment Outcome | 2010 |
[Efficacy of mexidol in the combination with thrombolytic therapy in patients with ischemic stroke].
Topics: Aged; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Picolines; Psychotropic Drugs; Stroke; Treatment Outcome | 2012 |
12 other study(ies) available for emoxypine succinate and Apoplexy
| Article | Year |
|---|---|
Topics: Animals; Apoptosis; Biomarkers; Brain Ischemia; Brain-Derived Neurotrophic Factor; Hematoma; Hemorrhagic Stroke; Humans; Ischemic Stroke; Male; Oxidative Stress; Phosphopyruvate Hydratase; Picolines; Prognosis; Quality of Life; Rats; Stroke; Tumor Suppressor Protein p53 | 2022 |
[The trial of the efficacy and safety of sequential therapy with Mexidol forte 250 in acute and early recovery stages of hemispheric ischemic stroke].
Topics: Brain Ischemia; Humans; Picolines; Quality of Life; Stroke; Treatment Outcome | 2020 |
Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats.
Topics: Animals; Brain Ischemia; Cerebrovascular Disorders; Dipeptides; Disease Models, Animal; Drug Administration Schedule; Injections, Intraperitoneal; Middle Cerebral Artery; Molecular Mimicry; Neuroprotective Agents; Neurotrophin 3; Picolines; Rats; Rats, Wistar; Stroke | 2017 |
[Evaluation of blood rheology by patients with acute ischemic stroke with Mexidol administration].
Topics: Blood Viscosity; Brain Ischemia; Erythrocyte Aggregation; Erythrocyte Deformability; Humans; Picolines; Platelet Aggregation Inhibitors; Regional Blood Flow; Rheology; Stroke | 2019 |
[Correction of psychoemotional and autonomic dysfunction in patients with ischemic stroke].
Topics: Aged; Antioxidants; Anxiety; Autonomic Nervous System Diseases; Brain Ischemia; Female; Humans; Male; Nootropic Agents; Picolines; Stroke | 2013 |
[Neurometabolic therapy in secondary prevention of stroke].
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Female; Humans; Male; Middle Aged; Picolines; Secondary Prevention; Stroke; Treatment Outcome | 2014 |
[Optimization of hypolipidemic therapy in patients with ischemic stroke and diabetes mellitus].
Topics: beta-Thromboglobulin; Blood Platelets; Diabetes Mellitus, Type 2; Female; Hemostasis; Humans; Hypolipidemic Agents; Lipids; Male; Middle Aged; Picolines; Prospective Studies; Stroke; Treatment Outcome; von Willebrand Factor | 2016 |
[Changes in the hemostasis system and free-radical lipid oxidation in the acute stage of ischemic stroke in patients on neuroprotection treatment].
Topics: Aged; Aged, 80 and over; Amino Acids; Female; Free Radicals; Hemostasis; Humans; Lipid Metabolism; Male; Middle Aged; Neuroprotective Agents; Oxidation-Reduction; Picolines; Platelet Aggregation Inhibitors; Stroke | 2012 |
[An influence of mexidol on the restoration of neurological deficit, increase of social adaptation and removal of neglect and push syndromes in stroke patients].
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Nervous System Diseases; Perceptual Disorders; Picolines; Psychotropic Drugs; Recovery of Function; Social Adjustment; Stroke; Stroke Rehabilitation | 2011 |
[Effects of mexidol on the functional state of the central nervous system in post-stroke patients].
Topics: Aged; Antioxidants; Cerebrum; Electroencephalography; Female; Hemodynamics; Humans; Male; Middle Aged; Picolines; Platelet Aggregation Inhibitors; Stroke; Stroke Rehabilitation | 2012 |
[Features of stroke rehabilitation].
Topics: Antioxidants; Humans; Picolines; Stroke; Stroke Rehabilitation | 2012 |
[Evolution in optimization of stroke treatment].
Topics: Antioxidants; Cytoprotection; Humans; Multicenter Studies as Topic; Neuroprotective Agents; Picolines; Stroke | 2012 |